Company” or " RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a definitive acquisition agreement with Canapar Corp. (“ Canapar”) and a wholly-owned subsidiary of the Company on May 11, 2021, that provides for the acquisition of all the common shares of Canapar (“ Canapar Shares”) that the Company does not currently own in exchange for an aggregate of approximately 21,904,095 common shares RAMM at a deemed value of $1.20 per Ramm Share (“ RAMM Shares”) for a total purchase price of approximately $26.2 million (the “ Transaction”). Based in Italy, Canapar is positioned to become one of Europe's largest vertically integrated cannabis companies. Canapar's state-of-the-art extraction facility is the largest in Europe and has been custom designed to produce active compounds to be used in high-quality pharmaceutical, wellness and cosmetic products from its 1,000-hectare organic hemp production and processing platform. The strategic acquisition is expected to further enhance RAMM and Canapar's ability to capitalize on the rapidly expanding European and global cannabis markets, provide additional distribution opportunities for RAMM's portfolio of internationally registered cannabis-based products, and leverage Canapar's significant investment in its vertically integrated operation to provide economies of scale and supply chain control.